Company intelligence / Profile preview

Acumenta Biotech

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Acumenta Biotech develops Literature Lab™, a software platform that automates interrogation and analysis of biomedical journal reports. The tool enables discovery research scientists in biotechnology, pharmaceutical, and academic settings to analyze gene expression data, identify biological processes and pathways, and accelerate research by providing actionable insights from over 35 million PubMed abstracts. It is widely used to enrich biological interpretation of findings in areas such as immunology and cardiovascular development.

Industry: Drug Discovery Services

Partnerships

Bantam Group

Beyond the preview

Go deeper on Acumenta Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acumenta Biotech.

Explore the full profile